Subscribe
Thursday, October 1, 2026
27.9 C
Bengaluru
type here...
Subscribe
Special Issue
Less than 1 min.Read

Interview with Salil Kallianpur

Anup Soans
By Anup Soans

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur - with Anup Soans, Editor - MedicinMan

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Market Intelligence

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...
MedicinMan Market Intelligence

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...
Ethics in Healthcare

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...
MedicinMan Market Intelligence

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...
MedicinMan Market Intelligence

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Topics

MedicinMan Market Intelligence

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...
MedicinMan Market Intelligence

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...
Ethics in Healthcare

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...
MedicinMan Market Intelligence

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...
MedicinMan Market Intelligence

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
MedicinMan Market Intelligence

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...
MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
spot_img

Related Articles

spot_imgspot_img
Previous article
Draft Pharma Policy
Next article
Dr. Tarun Gupta Tribute Issue

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk